calimmune, page-53

I have no idea Truliapro. There is a lot of water to flow under the bridge before we get to that stage but any positive efficacy data may well see a breakthrough status being allocated by the FDA. In theory this could allow some final testing to be done on paying patients, with extensive follow up.

An IPO may depend on whether or not Calimmune want to go all the way to market with this product or simply sell it off to the highest bidder.